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[57] ABSTRACT
An apparatus and method for testing the glucose level 
in a blood sample is provided. The method includes the 
step of initially filtering a sample of blood to be tested. 
A beam of light is provided and split into a pair of beams 
by a beam splitter. The pair of beams travel along gener­
ally parallel paths. One path contains a cell of a known 
optical pathlength and additionally a compensator. The 
other path has a cell containing the filtered blood sam­
ple to be tested. The pair of beams are then recombined 
by a mirror and a fringe pattern is detected at a detector. 
From the fringe pattern, the refractive index of the 
blood sample can be calculated. The refractive index is 
easily converted to a specific glucose concentration. 
Alternatively, the original fringe pattern can be re­
stored by changing the effect of the compensator. The 
refractive index can then be found from the required 
compensation.
11 Claims, 1 Drawing Sheet
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INTERFEROMETRIC MEASUREMENT OF 
GLUCOSE BY REFRACTIVE INDEX 
DETERMINATION
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates generally to a blood 
glucose monitoring apparatus and method.
2. Description of Related Art
There are approximately between 2 and 4 million 
people in the United States with diabetes. This amounts 
to about 2% of the population. Many of these people 
need to take one or more shots of insulin each day. As 
a result, there is a need to monitor the glucose level in 
the blood because these glucose levels often fluctuate 
due to several factors.
There are many devices on the market known for 
testing the blood glucose level. One such method is a 
chemical method using a dye indicator. The glucose in 
the blood reacts with a reagent and the final color is 
correlated with a different glucose concentration. This 
is done by utilizing a small plastic strip and the color is 
read by visual or photo-reflectance methods.
The accuracy of these tests, however, is relatively 
low. Their value mainly lies in that they are rapid and 
simple to use although the accuracy is low.
U.S. Pat. No. 4,704,029 to Van Heuvelen issued Nov. 
3,1987 discloses a blood glucose monitor. The assembly 
includes a light source which is split into a plurality of 
beams. One beam is a reference. The other beam is 
directed toward a prism having a blood sample therebe- 
hind to form a reflected beam. The intensity of the 
reflected beam is compared to the intensity of the refer­
ence beam. The angle at which the beam of light is 
directed at the blood sample is critical. The refractive 
index of the blood sample is measured by the intensity 
of the refractor beam. This assembly requires critical 
angle placement of the prism and blood supply with 
respect to the incident beam.
SUMMARY OF THE INVENTION
According to the present invention, there is provided 
an apparatus and a method of measuring the glucose 
level in a blood sample including measuring the index of 
refraction of the blood sample by splitting an original 
beam of light into a first and second beam. The first 
beam passes through a first cell containing the blood 
sample while the second beam passes through a second 
cell of known optical path length and a compensator 
also of known optical path length. The method finally 
comprises the steps of recombining the first and second 
beams to establish a fringe pattern and measuring the 
fringe pattern.
Accordingly, there is provided a rapid and accurate 
method to monitor the glucose level in the blood which 
is sensitive to changes in blood glucose concentration 
and relies only upon physical measurements thereby 
eliminating the need for chemical reagents.
Other advantages of the present invention will be 
readily appreciated as the same becomes better under­
stood by reference to the following description when 
considered in connection with the accompanying draw­
ings.
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BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 is a schematic view of an apparatus made in 
accordance with the present invention.
FIG. 2 is a block diagram showing an artifical pan­
creas utilizing the present invention.
DESCRIPTION OF THE PREFERRED 
EMBODIMENT
Referring to FIG. 1, an apparatus for interferometric 
measurement of glucose made in accordance with the 
present invention is generally shown at 10. The appara­
tus 10 includes a light source 12. The light source 12 is 
preferably a white light source. A monochromatic 
source may also be used. When using monochromatic 
light, identical final fringe patterns can exist for a vari­
ety of pathlengths. This makes it difficult to differenti­
ate between an increase or a decrease of the optical 
pathlength (and hence the refractive index) of the mate­
rial. By utilizing white light, the fringe pattern exists 
only when the pathlengths are equal.
The light source 12 produces an original beam 13. 
The beam 13 is directed at a beam splitting mirror 14. 
The beam splitting mirror 14 splits the beam 13 of light 
provided by the light source 12 into two separate paths 
16 and 20. Any suitable means for splitting the original 
beam 13 from the light source 12 into the pair of beams 
16 and 20 may be used.
The first path, denoted by 16, passes through a first 
cell 18. The length of the cell is determinable on the 
sensitivity desired. To calculate the length of the cell, 
the following refractive index table can be used as a 
representative of certain glucose levels.
TABLE 1
Refractive Index of Various Materials
Material Refractive Index
Water 1.3330
100 mg sugar/100 ml water 1.33310
110 mg sugar/100 ml water 1.33311
For a change in sugar concentration from 100 mg 
sugar/100 ml water to 110 mg sugar/100 ml water, the 
refractive index changes by 0.00001. For a change of 
this magnitude, a value of 100,000 (105) wavelengths is 
used to readily detect a change of the fringe pattern at 
detector 30. For an approximate value of 5000A as the 
average wavelength of white light, the path length of 
cell 18 can be calculated from the following equations, 
where 1.33 is the refractive index of water.
path length =  105 =  *  10- l g . a  4 cm
Therefore, approximately a 4 cm pathlength is used 
to detect a change at detector 30 for a glucose level 
change of 100 mg to 110 mg in a 100 ml solution. A 
change in refractive index by one part in 105 will shift 
the fringe pattern one fringe.
The second beam, denoted by 20, passes through a 
second cell 22. The length of the second cell 22 is pref­
erably the same as the length of the first cell 18. Further, 
the second beam 20 passes through a compensator 24. 
Both the first beam 16 and the second beam 20 are 
directed onto a combining mirror 26. The combining 
mirror 26 recombines the pair of light beams 16 and 20 
into a single beam 28. Again, any suitable means for 
recombining the beams 18 and 22 may be utilized within
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the scope of the present invention. The single final beam 
28 is directed or focused upon a detector 30. The detec­
tor 30 is generally a photodetector for measuring the 
intensity of the final beam 28. For a white light source, 
the intensity will be highest when path lengths 16 and 
20 are the same due to constructive interference. As the 
path lengths differ, due to the difference in refractive 
indexes of the solutions in cells 18 and 22, the interfer­
ence at detector 30 will be destructive, thus lessening 
the intensity virtually to zero.
Initially, apparatus 10 is calibrated by putting a solu­
tion of known and identical refractive index into both 
cells 18 and 22. Since the path lengths are the same, the 
intensity at detector 30 is the highest. Compensator 24 is 
set at a reference position. In use, a solution of unknown 
refractive index is put into cell 18. Since the refractive 
index is different than the calibration solution in cell 22, 
the path length is different. Thus, detector 30 receives 
considerably less illumination. Compensator 24 is then 
adjusted until the intensity of detector 30 is back to a 
maximum. From the amount of change in compensator 
24, the refractive index of the solution in cell 18 can be 
determined. This refractive index can then be used to 
determine the solutions glucose content.
According to the present invention, there is provided 
a method for testing the level of glucose in the blood 
stream. In order to test the blood glucose level, a known 
solution is placed into the first cell 18 and the second 
cell 22. The light source 12 is then illuminated produc­
ing the original beam 13. The beam 13 from the light 
source is split into a pair of beams 16 and 20 by beam 
splitting mirror 14. The first beam 16 passes through the 
first cell 18 containing a known solution and to the 
combining mirror 26. Simultaneously, the second beam 
20 passes through the second cell 22 containing a 
known solution and through the compensator 24 and is 
directed to the combining mirror 26. The two beams 16 
and 20 are recombined and the final beam 28 is sent to 
the detector 30. At the detector 30, a fringe pattern is 
established.
A sample of blood is then filtered to remove all com­
ponents exceeding a predetermined weight. Particu­
larly, cells and proteins having a molecular weight ex­
ceeding one thousand daltons are filtered out of the 
blood sample. This blood sample is then introduced into 
the first cell 18. When the filtered blood fills the cell 18, 
the recombined beam 30 will show a shift in the fringe 
pattern at the detector 30. The refractive index can be 
measured either from the shift in the fringe pattern 
when the sample is changed from the known solution to 
the unknown solution or from the compensation re­
quired at the compensator 24 to restore the original 
fringe pattern after the unknown solution or blood has 
been introduced. The compensation is achieved by 
changing the optical path length of the compensator 24 
by a known or predetermined amount.
The assumption is that the major change in the refrac­
tive index for the serum, the filtered blood sample, is 
due to a change in glucose concentration. If, however, 
the concentration of the electrolytes and simple organic 
compounds varies so as to appreciably change the re­
fractive index of the blood sample, then the appropriate 
quantities must be measured and properly accounted or 
compensated for. Many well known probes exist which 
could measure the electrolyte concentration for this 
purpose. Although it is not as easy to separate organic 
compounds, selective filters may be employed for this
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purpose or light absorption of these organic compounds 
can be measured and properly compensated.
Thus, the present invention has the advantage of 
providing a portable and accurate apparatus for rapidly 
and accurately measuring the glucose level from a small 
sample of blood. Further, the apparatus may be adapted 
to become a component of an implantable artificial 
pancreas generally shown at 40 in the block diagram of 
FIG. 2. This can be accomplished because no chemicals 
need to be replenished or eliminated for monitoring the 
blood glucose level. The apparatus or interferometer 
would be one component of an artificial pancreas. If 
utilized in such a manner, the blood stream 42 could 
continuously flow into the interferometer portion gen­
erally indicated at 44 of the artificial pancreas 40. It is 
noted that the interferometer portion 44 of the artificial 
pancreas 40 is as previously described and shown sche­
matically in FIG. 1. The blood stream 42 flows directly 
into the first cell of the apparatus. The blood glucose 
level could be continuously monitored and the informa­
tion sent to a probe controller generally indicated at 46 
which would in turn determine the required insulin 
output and send the information to the insulin pump 
generally indicated at 48. The insulin pump 48 injects 
the correct amount of insulin into the blood stream 42. 
With such a continuous feedback mechanism, the blood 
glucose concentration could be regulated much better 
than by present methods.
The present invention has been described in an illus­
trative manner. It is to be understood that the terminol­
ogy which has been used is intended to be a nature of 
words of description rather than of limitation.
Many modifications and variations of the present 
invention are possible in light of the above teachings. 
Therefore, within the scope of the appended claims, the 
present invention may be practiced otherwise than as 
specifically described.
What is claimed is:
1. A method of measuring the glucose level in a blood 
sample comprising the steps of:
placing a known solution into a first cell and second 
cell;
providing a light source for generating an original 
beam of light;
splitting the original beam of light into a first and 
second beam;
passing the first beam through the first cell while 
simultaneously passing the second beam through 
the second cell;
recombining the first and second beams into a final 
beam to establish a fringe pattern;
filtering a blood sample to remove all components 
exceeding a predetermined weight and placing the 
filtered blood sample into the first cell;
measuring a shift in the fringe pattern to determine 
the refractive index of the filtered blood sample.
2. A method as set forth in claim 1 including the step 
of utilizing a white light source for providing the origi­
nal beam.
3. A method of measuring the glucose level in a blood 
sample comprising the steps of:
placing a known solution into a first cell and a second 
cell;
providing a light source for generating an original 
beam of light;
splitting the original beam of light into a first and 
second beam;
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passing the first beam through the first cell while 
simultaneously passing the second beam through 
the second cell;
recombining the first and second beam into a final 
beam to establish a fringe pattern; 
filtering a blood sample to remove all components 
exceeding a predetermined weight; 
placing the filtered blood sample into the first cell; 
measuring a refractive index of the filtered blood 
sample based on the fringe pattern; and 
calculating the glucose level in the filtered blood 
sample based on the measured refractive index.
4. A method of measuring the glucose level in a blood 
sample comprising the steps of:
placing a known solution into a first and second cell; 
providing a light source for generating an original 
beam of light;
splitting the original beam of light into a first and 
second beam;
passing the first beam through the first cell while 
simultaneously passing the second beam through 
the second cell;
passing the second beam of light through a compensa­
tor;
recombining the first and second beams into a final 
beam to establish a fringe pattern; 
filtering a blood sample to remove all components 
exceeding a predetermined weight; 
placing the filtered blood sample into the first cell; 
and
measuring the refractive index of the filtered blood 
sample based on the fringe pattern.
5. A method of measuring the glucose level in a blood 
sample comprising the steps of:
placing a known solution into a first and second cell; 
providing a light source for generating an original 
beam of light;
splitting the original beam of light into a first and 
second beam;
passing the first beam through the first cell while 
simultaneously passing the second beam through 
the second cell and a compensator; 
recombining the first and second beams into a final 
beam to establish an original fringe pattern; 
filtering a blood sample to remove all components 
exceeding a predetermined weight; 
placing the filtered blood sample in the first cell; 
calculating the glucose level in the filtered blood 
sample by adjusting the compensator to restore the 
original fringe pattern.
6. A method of measuring the glucose level in a blood 
sample comprising the steps of:
placing a known solution into a first and second cell; 
providing a light source for generating an original 
beam of light;
splitting the original beam of light into a first and 
second beam;
passing the first beam through the first cell while 
simultaneously passing the second beam through 
the second cell;
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recombining the first and second beams into a final 
beam to establish a fringe pattern; 
filtering the blood sample to remove all components 
having a molecular weight exceeding one thousand 
daltons;
placing the filtered blood sample into the first cell; 
and
measuring the refractive index of the filtered blood 
sample based on the fringe pattern.
7. A method of measuring the glucose level of blood 
comprising the steps of:
filtering a sample of blood to remove cells and prote­
ins exceeding a predetermined weight; 
providing a light source for generating an original 
beam;
splitting the original beam into first and second 
beams;
placing a first cell containing the filtered blood sam­
ple into the first beam of light; 
placing a second cell in the second beam; 
recombining the beams of light after each has passed 
through its respective cell to form a final beam; and 
measuring the fringe pattern of the final beam to 
determine the refractive index of the blood sample.
8. A method of measuring the glucose level of blood 
comprising the steps of:
filtering a sample of blood to remove cells and prote­
ins exceeding a predetermined weight; 
providing a light source for generating an original 
beam;
splitting the original beam into first and second 
beams;
placing a first cell containing the filtered blood sam­
ple into the first beam of light; 
placing a second cell in the second beam; 
recombining the beams of light after each has passed 
through its respective cell to form a final beam; and 
restoring the original fringe pattern using a compen­
sator to determine the refractive index of the blood 
sample.
9. A device for measuring the glucose level in a blood 
sample comprising:
a light source for producing a beam of light; 
a first mirror for separating the beam of light into a 
first beam and a second beam; 
a first cell containing a blood sample positioned in 
said first beam;
a second cell containing a known solution positioned 
in said second beam;
a second mirror for recombining said first beam and 
said second beam into a single light beam; and 
a photodetector for detecting the intensity of the 
recombined beam to determine the refractive index 
and glucose level of the blood sample.
10. The device of claim 9 including compensator 
means adjustable to compensate for the difference in 
path lengths of said first beam and said second beam to 
make the path length of said second beam the same as 
the path length of said first beam.
11. The device of claim 9 wherein said light source is 
a white light source.
* * * * *
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